{"id":"tp-52924","type":"article-newspaper","title":"Aura Biosciences Posts $0.29 GAAP Loss Per Share for Q3 2026","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52924","datePublished":"2026-11-10T08:28:23.000Z","dateModified":"2026-11-10T08:28:23.000Z","language":"en","abstract":"The company had $297.2 million in cash, cash equivalents and marketable securities as of Sept. 30 and said it believes those resources can fund operations into the first half of 2029.","section":"Business","references":[]}